Omega-3 fatty acids for skin: EPA, DHA, and what the evidence shows
A science-based guide to omega-3 fatty acids for skin — how EPA and DHA reduce skin inflammation, evidence for eczema, psoriasis, and photoprotection, whether topical or oral is more effective, and dosing guidance.
· By MedSpot Editorial · 4 min read
Omega-3 fatty acids have one of the largest evidence bases of any supplement for systemic health — including cardiovascular protection, inflammation reduction, and brain function. Their skin-specific effects are supported by a distinct and meaningful body of research. Here's what the evidence actually shows for skin.
The relevant omega-3s for skin
EPA (eicosapentaenoic acid): The primary anti-inflammatory omega-3 for skin. EPA is metabolized to the 3-series prostaglandins (PGE3) and 5-series leukotrienes — which are anti-inflammatory compared to the pro-inflammatory 2-series and 4-series produced from arachidonic acid. EPA also directly inhibits the enzyme COX-2 (cyclooxygenase-2), reducing inflammatory prostaglandin synthesis.
DHA (docosahexaenoic acid): The primary structural omega-3 in cell membranes. DHA increases membrane fluidity in keratinocytes and sebocytes, modulating how cells respond to UV and inflammatory signals. DHA also converts to resolvin D-series — pro-resolving mediators that actively turn off inflammation rather than just suppressing it.
ALA (alpha-linolenic acid): Plant-derived omega-3 found in flaxseed, chia, walnuts. The body can convert ALA to EPA and DHA, but conversion efficiency is low (typically <5–10% for EPA, <0.5% for DHA). ALA-rich plant oils are not equivalent to fish oil for skin-specific omega-3 effects.
How omega-3s affect skin
Inflammation reduction: The EPA → 3-series prostaglandin pathway directly competes with the arachidonic acid → 2-series prostaglandin pathway. Higher EPA intake shifts this ratio, reducing inflammatory signaling in skin. This is directly relevant for inflammatory skin conditions: acne, eczema, psoriasis, and UV-induced photoaging.
Photoprotection: EPA has a specific photoprotective mechanism beyond general antioxidant activity: it reduces UV-induced immunosuppression. UV radiation suppresses local skin immune function — EPA supplementation partially counters this effect. Multiple human studies show EPA supplementation reduces UV-induced erythema (sunburn) at equivalent UV doses.
Sebum regulation: EPA reduces sebum production via inhibition of 5-LOX (5-lipoxygenase), reducing leukotriene B4 — a pro-inflammatory signaling molecule that drives sebocyte activity. This is a distinct mechanism from retinoids or spironolactone but with the same directional outcome.
Barrier function: DHA's structural integration into keratinocyte membranes improves membrane fluidity and signaling, supporting barrier function. Low omega-3 status correlates with higher TEWL in epidemiological studies.
The clinical evidence
Eczema: Birch et al. (2010, British Journal of Dermatology): Meta-analysis of 9 RCTs found omega-3 supplementation produced statistically significant improvement in eczema severity scores, though effect sizes were modest. Most effective in children and in studies using EPA + DHA rather than ALA alone.
Psoriasis: A 2014 Cochrane Review (Millsop et al.) found omega-3 supplementation improved psoriasis Area and Severity Index (PASI) scores in most included RCTs, with EPA specifically showing more consistent benefit than DHA alone.
Acne: Khayef et al. (2012, Lipids in Health and Disease): A 10-week RCT of omega-3 + antioxidant supplementation reduced inflammatory and non-inflammatory acne lesion counts significantly vs. control. Mechanism consistent with leukotriene B4 suppression.
Photoprotection: Rhodes et al. (2003, Journal of Investigative Dermatology): Human subjects supplemented with 4g EPA daily for 3 months showed significantly reduced UV-induced erythema (sunburn redness) and reduced UV-induced DNA damage markers. This is among the cleaner human evidence for omega-3 UV protection.
Anti-aging: Epidemiological data links higher omega-3 dietary intake to less photoaging. The Nurses' Health Study found higher fish intake correlated with less severe skin aging. Mechanistic evidence (inflammation reduction, UV protection) supports this association.
Topical omega-3s vs. oral supplementation
Oral supplementation has essentially all the clinical evidence. The anti-inflammatory effects operate systemically — changing the prostaglandin and leukotriene balance throughout the body including skin.
Topical omega-3 oils (flaxseed oil, fish oil, some seed oils): Can deliver ALA and EPA to the skin surface, where they integrate into keratinocyte membranes locally. Limited topical-specific clinical evidence, but mechanistically plausible for local barrier effects.
Practical answer: Oral supplementation is the evidence-backed approach for systemic skin conditions (eczema, psoriasis, acne, photoprotection). High-omega-3 oils applied topically (flaxseed, hemp seed) provide local barrier-supportive fatty acids without the systemic EPA/DHA effect.
Dosing for skin benefits
Evidence-based doses from clinical trials:
- Eczema/psoriasis: 2–4g EPA + DHA daily, usually as fish oil
- UV photoprotection: 4g EPA daily (Rhodes et al.)
- Acne: 1–3g EPA + DHA daily
Timeline: Consistent with other anti-inflammatory interventions — expect 8–12 weeks of supplementation before significant skin improvement.
Supplement quality matters:
- Look for third-party tested products (IFOS certification or similar)
- EPA:DHA ratio varies; EPA is more relevant for anti-inflammatory skin effects
- Enteric coating reduces fish burp side effects
- Refrigerate to prevent rancidity
Who benefits most
Inflammatory skin conditions (eczema, psoriasis, acne): The primary evidence base. Omega-3 supplementation is a reasonable adjunct to conventional treatment.
Photoaging prevention: Patients spending significant time in the sun — omega-3's UV-protective and anti-inflammatory properties provide meaningful additive protection alongside SPF.
Dry, dehydrated skin with compromised barrier: DHA integration into cell membranes supports barrier function improvement over time.
Hormonal acne: EPA's leukotriene B4 suppression and sebum reduction are worth adding to a comprehensive approach.
Looking for skincare providers? Browse med spa and skincare providers on MedSpot →